Back to results
US 2018/0021274 A1Published application
Compositions comprising beta-hydroxybutyric acid and salt, and methods of using the same
AssigneeSavind, Inc.
InventorPatrick Arnold
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSavind, Inc.
InventorPatrick Arnold
Estimating the term…
β-hydroxybutyric acid in combination with β-hydroxybutyrate salts are useful to induce ketosis, achieving blood ketone levels of (0.5-6.0 mmol/L), with or without dietary restriction, and without inducing harmfully high mineral loads in the blood. The combination of β-hydroxybutyric acid and salt results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance & endurance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. These acid/salt mixtures are also useful for suppressing appetite, preventing epileptic seizures, and treating cancer.
A composition comprising ii-hydroxybutyric free acid and β-hydroxybutyrate salt, wherein the free acid and salt stand in a mass:mass ratio from ˜125 parts free acid:
ering to the individual an aqueous solution of the composition of claim 1.
tion of claim 1 to an epileptic patient.
tion of claim 1 to a cancer patient.
of the composition of claim 1 to an individual.
position of claim 1 to an individual.
omposition of claim 11, wherein the salt is a mixture of potassium and sodium salts.
The composition of claim 12, wherein the free acid and salt stand in a mass:mass:mass ratio from ˜125 parts free acid:
A method of inducing ketosis in an individual in need thereof, the method comprising
A method of treating epilepsy, the method comprising administering an effective amount of the
A method of treating cancer, the method comprising administering an effective amount of the
A method of increasing athletic endurance, the method comprising administering an effective
A method of suppressing appetite, the method comprising administering an effective amount of
The method of claim 28, wherein average blood glucose concentration is at least 5% less in the patient at a time one week after the administration than it is on the day before administration.
Dependencies are inferred from the claim text.